Pharmacovigilance course

What pharmacovigilance is

The World Health Organization describes pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem. The work continues after a medicine is licensed, because trials cannot show every effect in every kind of patient.

A single patient report is an individual case safety report, an ICSR. Teams also look across many reports. That wider look is aggregate reporting and signal management: noticing a pattern that may need more study. Dictionaries such as MedDRA (for medical terms) and WHODrug (for medicine names) keep those reports coded the same way from one company to another.

The same ideas are used worldwide. Europe publishes good pharmacovigilance practice. The United States, India and other regulators have their own reporting rules. A course can teach the shared method. The exact clock for a report still depends on the regulator and the seriousness of the case.

Roles

A drug-safety associate, sometimes called a case processor, takes in reports, checks that the case is valid, codes the terms, and writes the narrative. Senior associates review that work. Other roles cover aggregate reports such as periodic safety update reports, signal detection, safety databases, and quality checks before an inspection.

A physician or a pharmacist may review cases that need a medical opinion. In some regions a company names a qualified person for pharmacovigilance who is accountable for the system. Those are different jobs. A first course is usually aimed at the case-processing and review work a graduate can learn.

Skills

The useful skills are careful reading, a working knowledge of adverse drug reactions, and the habit of writing so that another person can see why a decision was made. People learn the parts of an ICSR, how to code with MedDRA, and how a safety database stores a case.

The PharmaWiz pharmacovigilance page lists twelve modules: an introduction and glossary, adverse drug reactions, the regulatory framework, the ICSR, MedDRA and WHO drug dictionaries, sources of information in a case, case processing, aggregate reports and signal management, safety databases, the roles of a PV professional, career readiness, and a mock interview. Abdul Azeem teaches this track.

Career path

A common path starts with case intake and processing. With time, people move to review, aggregate reports, or signal work. Some move into quality, training, or the medical-review side if their degree and experience support it. The path is not one ladder, and a course does not by itself decide the job.

Drug-safety teams sit inside pharmaceutical companies and inside firms that process safety cases for those companies. The work is done in many countries, including India, so a Hyderabad classroom and a remote team can be learning the same method.

How to start

A pharmacy, Pharm D, or other life-sciences degree is the usual base, because the reports are medical. Start by learning what an adverse reaction is, what makes a case valid, and how MedDRA is organised. Then practise writing a narrative from a sample report.

PharmaWiz teaches the published courses at KPHB Phase-I, Road No. 1, Kukatpally, Hyderabad, or live on Microsoft Teams. ASCEND, the programme those courses sit inside, is 4 months and 120 hours. The pharmacovigilance page says the course is for B.Pharm, M.Pharm, Pharm D and life sciences graduates, and that the certificate is a PharmaWiz certificate.

Questions